FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION

Detalles Bibliográficos
Main Authors:	Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, B, Bell, D
Formato:	Journal article
Publicado:	1988

Títulos similares

The prevalence of primary Sjogren's syndrome in a multiple sclerosis population.
por: Noseworthy, J, et al.
Publicado: (1989)

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY
por: Noseworthy, J, et al.
Publicado: (1990)

Sjögren's syndrome myelopathy: Spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica
por: Kim, S, et al.
Publicado: (2009)

Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.
por: Kim, S, et al.
Publicado: (2009)

TIZANIDINE VERSUS BACLOFEN IN THE TREATMENT OF SPASTICITY IN PATIENTS WITH MULTIPLE-SCLEROSIS - A DOUBLE-BLIND-STUDY
por: Bass, B, et al.
Publicado: (1987)

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
por: Min, J, et al.
Publicado: (2009)

THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS - A GEOGRAPHICALLY BASED STUDY
por: Weinshenker, B, et al.
Publicado: (1989)

Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.
por: Bass, B, et al.
Publicado: (1988)

An open trial of OKT3 in patients with multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado: (1991)

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
por: Weinshenker, BG, et al.
Publicado: (1989)

A PRELIMINARY CLINICAL-TRIAL OF ORTHOCLONE OKT-STAR-3 TREATMENT IN CHRONICALLY PROGRESSIVE MULTIPLE-SCLEROSIS
por: Weinshenker, B, et al.
Publicado: (1988)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
por: Noseworthy, J, et al.
Publicado: (1989)

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
por: Weinshenker, BG, et al.
Publicado: (1989)

Primary progressive multiple sclerosis: Brain MRI findings
por: Kremenchutzky, M, et al.
Publicado: (1999)

Primary biliary cirrhosis and multiple sclerosis.
por: Noseworthy, J, et al.
Publicado: (1989)

Myelopathy in primary Sjogren's syndrome: diagnostic and therapeutic aspects.
por: Hermisson, M, et al.
Publicado: (2002)

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
por: Noseworthy, J, et al.
Publicado: (1989)

Diagnostic brain MRI findings in primary progressive multiple sclerosis.
por: Kremenchutzky, M, et al.
Publicado: (2000)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado: (1992)

Are patients with primary Sjogren's syndrome at increased risk of cardiovascular disease?
por: Manhas, R, et al.
Publicado: (2008)

'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjogren's syndrome.
por: Plater-Zyberk, C, et al.
Publicado: (1989)

An immunohistological study of secondary Sjogren's syndrome.
por: Isenberg, D, et al.
Publicado: (1984)

Interpretation of single band patterns in CSF protein electrophoresis.
por: Bass, B, et al.
Publicado: (1988)

SIGNIFICANCE OF THE SINGLE BAND IN CSF PROTEIN ELECTROPHORESIS
por: Bass, B, et al.
Publicado: (1986)

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
por: Noseworthy, J, et al.
Publicado: (1989)

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.
por: Weinshenker, BG, et al.
Publicado: (1991)

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
por: Weinshenker, BG, et al.
Publicado: (1991)

Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.
por: Harpur, G, et al.
Publicado: (1986)

A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome
por: Stack, R, et al.
Publicado: (2017)

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL
por: Noseworthy, J, et al.
Publicado: (1990)

SLE presenting as parotitis and secondary Sjogren’s syndrome
por: Mohd Shah, Azarisman Shah, et al.
Publicado: (2007)

Current Concepts : Mouse Models of Sjögren’s Syndrome
por: Lavoie, Tegan N., et al.
Publicado: (2011)

CHRONIC DYSPAREUNIA - SJOGREN SYNDROME - ANOTHER CLINICAL PRESENTATION
por: Sheeran, T, et al.
Publicado: (1992)

The natural history of multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado: (1987)

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
por: Noseworthy, J, et al.
Publicado: (1990)

Systemic interferon alfa in multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado: (1989)

Secondary Sjogrens syndrome, immunological and histopathological study in female
por: Mustafa Al-Ahmad, Basma Ezzat, et al.
Publicado: (2011)

Sjogren's syndrome-associated myelopathy: response to immunosuppressive treatment.
por: Vincent, T, et al.
Publicado: (2003)

Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
por: Wiebe, S, et al.
Publicado: (1992)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
por: Weinshenker, BG, et al.
Publicado: (1989)